Cargando…

Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial

OBJECTIVES: Active immunization, or vaccination, with tumor necrosis factor (TNF)-Kinoid (TNF-K) is a novel approach to induce polyclonal anti-TNF antibodies in immune-mediated inflammatory diseases. This study was performed to transfer the proof of concept obtained in mice model of rheumatoid arthr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durez, Patrick, Vandepapeliere, Pierre, Miranda, Pedro, Toncheva, Antoaneta, Berman, Alberto, Kehler, Tatjana, Mociran, Eugenia, Fautrel, Bruno, Mariette, Xavier, Dhellin, Olivier, Fanget, Bernard, Ouary, Stephane, Grouard-Vogel, Géraldine, Boissier, Marie-Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269456/ https://www.ncbi.nlm.nih.gov/pubmed/25517733 http://dx.doi.org/10.1371/journal.pone.0113465

Ejemplares similares

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
por: Ducreux, Julie, et al.
Publicado: (2016)

Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
por: Sigaux, Johanna, et al.
Publicado: (2017)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts
por: Bouget, Vincent, et al.
Publicado: (2022)

The Effect of TNF-α on CHD and the Relationship between TNF-α Antagonist and CHD in Rheumatoid Arthritis: A Systematic Review
por: Qian, Yezhou, et al.
Publicado: (2022)

Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis
por: Furuya, Hidekazu, et al.
Publicado: (2013)

Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
por: Lim, Heejin, et al.
Publicado: (2018)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016)

Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
por: Cui, Xiaofang, et al.
Publicado: (2018)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Treating psoriatic arthritis: how effective are TNF antagonists?
por: Gottlieb, Alice B, et al.
Publicado: (2004)

Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
por: Brymer, Kyle J., et al.
Publicado: (2019)

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
por: Fisher, Anat, et al.
Publicado: (2014)

New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
por: Feldmann, M, et al.
Publicado: (2001)

Does route of administration affect the outcome of TNF antagonist therapy?
por: Schwartzman, Sergio, et al.
Publicado: (2004)

Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF–TNF-RII binding in rheumatoid arthritis
por: Nguyen, Dao Xuan, et al.
Publicado: (2016)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort
por: Theunssens, Xavier, et al.
Publicado: (2022)

TNF-alpha blockade by nonviral gene therapy in collagen-induced arthritis
por: Boissier, MC, et al.
Publicado: (2003)

Weight-Based Adaptation of TNF-Antagonist Induction versus Maintenance Dose
por: Navarini, Alexander A., et al.
Publicado: (2011)

Does safety make a difference in selecting the right TNF antagonist?
por: Fleischmann, Roy, et al.
Publicado: (2004)

IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα
por: Shekhar, Tanmay M., et al.
Publicado: (2016)

Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series
por: Thery-Casari, Clémence, et al.
Publicado: (2018)

Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis
por: Stievenart, Julien, et al.
Publicado: (2021)

Could TNF-antagonists be a novel treatment strategy for BPH patients?
por: Vickman, Renee E., et al.
Publicado: (2022)

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
por: Carmona, Loreto, et al.
Publicado: (2006)

Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
por: Germano, Valentina, et al.
Publicado: (2014)

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
Publicado: (1991)

TNF and anti-TNF agents in Behçet's disease
por: Calamia, KT
Publicado: (2003)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
por: Li, Xuefei, et al.
Publicado: (2023)

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
por: Navarro-Sarabia, Federico, et al.
Publicado: (2009)

Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist
por: Kopec-Medrek, Magdalena, et al.
Publicado: (2011)

Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
por: Fausel, Rebecca, et al.
Publicado: (2015)

Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
por: Cludts, Isabelle, et al.
Publicado: (2017)

The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists
por: Cappello, Maria, et al.
Publicado: (2021)

Transmembrane TNF-dependent uptake of anti-TNF antibodies
por: Deora, Arun, et al.
Publicado: (2017)

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c0dikhjib079cm62f3euullqjt